CM Life Sciences Inc.

NASDAQ: CMLFU · Real-Time Price · USD
13.00
-0.62 (-4.55%)
At close: Nov 16, 2020, 6:00 AM

CM Life Sciences Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024
Period Ending Dec 31, 2024
Revenue
305.45M
Cost of Revenue
111.05M
Gross Profit
194.4M
Operating Income
-23.21M
Interest Income
n/a
Pretax Income
-52.63M
Net Income
-52.29M
Selling & General & Admin
168.48M
Research & Development
45.72M
Other Expenses
n/a
Operating Expenses
214.2M
Interest Expense
-3.03M
Selling & Marketing Expenses
67.37M
Cost & Expenses
325.26M
Income Tax Expense
-343K
Shares Outstanding (Basic)
26.89M
Shares Outstanding (Diluted)
26.89M
EPS (Basic)
-1.94
EPS (Diluted)
-1.94
EBITDA
-23.21M
EBIT
n/a
Depreciation & Amortization
n/a